PMC:7127386 / 3763-3943 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"113","span":{"begin":140,"end":144},"obj":"Gene"},{"id":"114","span":{"begin":163,"end":167},"obj":"Gene"},{"id":"139","span":{"begin":5,"end":14},"obj":"Chemical"},{"id":"140","span":{"begin":50,"end":58},"obj":"Chemical"},{"id":"141","span":{"begin":169,"end":180},"obj":"Chemical"}],"attributes":[{"id":"A113","pred":"tao:has_database_id","subj":"113","obj":"Gene:6622"},{"id":"A114","pred":"tao:has_database_id","subj":"114","obj":"Gene:3569"},{"id":"A139","pred":"tao:has_database_id","subj":"139","obj":"MESH:D000069454"},{"id":"A140","pred":"tao:has_database_id","subj":"140","obj":"MESH:C540945"},{"id":"A141","pred":"tao:has_database_id","subj":"141","obj":"MESH:C502936"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"vir, darunavir), reverse transcriptase inhibitor (Azvudine), anti-influenza compounds, interferon alfa-2b, or monoclonal antibody targeting PD-1 (Camrelizumab) or IL-6 (Tocilizumab"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T5","span":{"begin":121,"end":129},"obj":"Body_part"}],"attributes":[{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"vir, darunavir), reverse transcriptase inhibitor (Azvudine), anti-influenza compounds, interferon alfa-2b, or monoclonal antibody targeting PD-1 (Camrelizumab) or IL-6 (Tocilizumab"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T20","span":{"begin":66,"end":75},"obj":"Disease"}],"attributes":[{"id":"A20","pred":"mondo_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"}],"text":"vir, darunavir), reverse transcriptase inhibitor (Azvudine), anti-influenza compounds, interferon alfa-2b, or monoclonal antibody targeting PD-1 (Camrelizumab) or IL-6 (Tocilizumab"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T50","span":{"begin":5,"end":14},"obj":"Chemical"},{"id":"T51","span":{"begin":17,"end":48},"obj":"Chemical"},{"id":"T53","span":{"begin":25,"end":48},"obj":"Chemical"},{"id":"T54","span":{"begin":39,"end":48},"obj":"Chemical"},{"id":"T55","span":{"begin":87,"end":97},"obj":"Chemical"},{"id":"T56","span":{"begin":140,"end":142},"obj":"Chemical"},{"id":"T57","span":{"begin":163,"end":165},"obj":"Chemical"}],"attributes":[{"id":"A50","pred":"chebi_id","subj":"T50","obj":"http://purl.obolibrary.org/obo/CHEBI_367163"},{"id":"A51","pred":"chebi_id","subj":"T51","obj":"http://purl.obolibrary.org/obo/CHEBI_53756"},{"id":"A52","pred":"chebi_id","subj":"T51","obj":"http://purl.obolibrary.org/obo/CHEBI_59897"},{"id":"A53","pred":"chebi_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/CHEBI_37416"},{"id":"A54","pred":"chebi_id","subj":"T54","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A55","pred":"chebi_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/CHEBI_52999"},{"id":"A56","pred":"chebi_id","subj":"T56","obj":"http://purl.obolibrary.org/obo/CHEBI_74756"},{"id":"A57","pred":"chebi_id","subj":"T57","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A58","pred":"chebi_id","subj":"T57","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"}],"text":"vir, darunavir), reverse transcriptase inhibitor (Azvudine), anti-influenza compounds, interferon alfa-2b, or monoclonal antibody targeting PD-1 (Camrelizumab) or IL-6 (Tocilizumab"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T1","span":{"begin":25,"end":38},"obj":"http://purl.obolibrary.org/obo/GO_0003968"},{"id":"T2","span":{"begin":25,"end":38},"obj":"http://purl.obolibrary.org/obo/GO_0003899"}],"text":"vir, darunavir), reverse transcriptase inhibitor (Azvudine), anti-influenza compounds, interferon alfa-2b, or monoclonal antibody targeting PD-1 (Camrelizumab) or IL-6 (Tocilizumab"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T95","span":{"begin":5,"end":14},"obj":"DG_13"},{"id":"T96","span":{"begin":39,"end":48},"obj":"CHEBI:35222;CHEBI:35222"},{"id":"T97","span":{"begin":76,"end":85},"obj":"CHEBI:36357;CHEBI:36357"},{"id":"T98","span":{"begin":121,"end":129},"obj":"GO:0042571"},{"id":"T99","span":{"begin":140,"end":144},"obj":"PR:000001919"},{"id":"T100","span":{"begin":163,"end":167},"obj":"PR:000001393"},{"id":"T101","span":{"begin":169,"end":180},"obj":"DG_35"},{"id":"T20478","span":{"begin":80,"end":85},"obj":"NCBITaxon:10239"},{"id":"T47394","span":{"begin":175,"end":178},"obj":"CHEBI:60004;CHEBI:60004"}],"text":"vir, darunavir), reverse transcriptase inhibitor (Azvudine), anti-influenza compounds, interferon alfa-2b, or monoclonal antibody targeting PD-1 (Camrelizumab) or IL-6 (Tocilizumab"}